+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gene Editing Technologies Market by Technology Platform, Application, End User, Delivery Method, Disease Indication - Global Forecast to 2030- Product Image
Gene Editing Technologies Market by Technology Platform, Application, End User, Delivery Method, Disease Indication - Global Forecast to 2030- Product Image
Sale

Gene Editing Technologies Market by Technology Platform, Application, End User, Delivery Method, Disease Indication - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924703
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Gene editing technologies are rapidly shaping a new paradigm in life sciences, enabling precisely targeted interventions across therapeutics, agriculture, and industrial biotechnology. Industry leaders are leveraging advancements in CRISPR, base editing, and prime editing platforms, driving diverse applications and fostering global collaboration across the innovation value chain.

Market Snapshot: Gene Editing Technologies Market

The Gene Editing Technologies Market grew from USD 5.73 billion in 2024 to USD 6.48 billion in 2025. It is expected to continue growing at a CAGR of 12.72%, reaching USD 11.75 billion by 2030. Market expansion is underpinned by technological advancements and adoption in multiple domains, ranging from clinical therapeutics to agriculture and industrial research. Stakeholders are capitalizing on an increasingly globalized landscape, marked by robust R&D investments, emerging delivery systems, and evolving regulatory frameworks.

Scope & Segmentation

  • Technology Platforms: CRISPR (including base, adenine, cytosine, Cas9, prime editing), meganuclease, TALEN, ZFN.
  • Applications: Agricultural (crops, livestock), industrial (biofuels, bioplastics), research tools (assays, cell line engineering, library screening), and therapeutic (ex vivo immunotherapy, stem cell therapy, in vivo germline and somatic editing).
  • End Users: Biopharmaceutical companies (large, small, and medium), contract research organizations (clinical, preclinical), medical centers, hospitals, research institutes, academic centers, academic research, government laboratories.
  • Delivery Methods: Nonviral (electroporation, lipid nanoparticle, microinjection), viral (adeno associated virus, lentivirus, retrovirus).
  • Disease Indications: Infectious diseases, oncology (hematological malignancies, solid tumors), rare genetic disorders (cystic fibrosis, sickle cell disease).
  • Regions: Americas (notably United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, UAE, Saudi Arabia, South Africa, and more), Asia-Pacific (China, India, Japan, Australia, South Korea, etc.).
  • Companies Analyzed: Thermo Fisher Scientific, Danaher, Merck KGaA, Roche Holding, Agilent Technologies, Sartorius AG, Bio-Rad Laboratories, QIAGEN, Lonza Group, Takara Bio.

Key Takeaways for Decision-Makers

  • Diversifying gene editing platform investment mitigates concentration risk and offers flexibility to deploy new technological advances as they arise.
  • The competitive landscape is shifting through strategic alliances and consolidation, integrating precision editing into biopharma pipelines and contract services.
  • Adoption rates in research and clinical settings reflect improved accessibility and collaborative R&D productivity, supported by enhancements in editing accuracy and safety.
  • Regulatory developments focus on adaptive frameworks that foster a balance between innovation, biosafety, and harmonized trial protocols across regions.
  • Building regional supply networks and strengthening domestic production strategies support resilience against logistical and trade-related disruptions.
  • Intellectual property management and open licensing are promoting broader access to foundational editing technologies while accelerating cross-sector innovation.

Tariff Impact: Responding to 2025 US Tariffs

Recent US tariff measures have increased costs for gene editing reagents and equipment, compelling organizations to reconsider sourcing strategies and renegotiate supplier terms. These shifts have triggered delays in project timelines and prompted some research-focused organizations to reduce discretionary spending. In response, industry players are enhancing domestic production, building strategic alliances with local suppliers, and participating in consortia to establish shared resources. These collective strategies are designed to maintain operational continuity and preserve innovation momentum in the face of evolving trade policies.

Methodology & Data Sources

This report synthesizes comprehensive secondary research—including peer-reviewed journals, industry filings, patents, and regulatory documentation—with primary interviews of senior executives and scientific leaders. Data triangulation, expert peer review, and regional analysis ensure insights are accurate, actionable, and reflect a broad industry perspective.

Why This Report Matters

  • Offers decision-makers a clear understanding of market segmentation, regional trends, and technology adoption for strategic planning.
  • Enables rapid response to emergent risks and opportunities by clarifying regulatory, trade, and partnership dynamics.
  • Supports prioritization of R&D and supply chain investment for sustainable, competitive positioning in the gene editing market.

Conclusion

Gene editing technologies are transforming life sciences across multiple sectors. This report equips industry leaders with critical insights for adaptive strategy development, helping organizations navigate a complex, high-growth market environment with clarity and confidence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Gene Editing Technologies Market, by Technology Platform
8.1. Introduction
8.2. CRISPR
8.2.1. Base Editing
8.2.1.1. Adenine Base Editing
8.2.1.2. Cytosine Base Editing
8.2.2. Cas9
8.2.3. Prime Editing
8.3. Meganuclease
8.4. TALEN
8.5. ZFN
9. Gene Editing Technologies Market, by Application
9.1. Introduction
9.2. Agricultural
9.2.1. Crops
9.2.2. Livestock
9.3. Industrial
9.3.1. Biofuels
9.3.2. Bioplastics
9.4. Research Tools
9.4.1. Assays
9.4.2. Cell Line Engineering
9.4.3. Library Screening
9.5. Therapeutic
9.5.1. Ex Vivo
9.5.1.1. Immunotherapy
9.5.1.2. Stem Cell Therapy
9.5.2. in Vivo
9.5.2.1. Germline Gene Editing
9.5.2.2. Somatic Gene Editing
10. Gene Editing Technologies Market, by End User
10.1. Introduction
10.2. Biopharmaceutical Companies
10.2.1. Large Biopharma
10.2.2. Small and Medium Biopharma
10.3. Contract Research Organizations
10.3.1. Clinical
10.3.2. Preclinical
10.4. Medical Centers and Hospitals
10.4.1. Clinics
10.4.2. Hospitals
10.5. Research Institutes and Academic Centers
10.5.1. Academic Research
10.5.2. Government Laboratories
11. Gene Editing Technologies Market, by Delivery Method
11.1. Introduction
11.2. Nonviral
11.2.1. Electroporation
11.2.2. Lipid Nanoparticle
11.2.3. Microinjection
11.3. Viral
11.3.1. Adeno Associated Virus
11.3.2. Lentivirus
11.3.3. Retrovirus
12. Gene Editing Technologies Market, by Disease Indication
12.1. Introduction
12.2. Infectious Diseases
12.3. Oncology
12.3.1. Hematological Malignancies
12.3.2. Solid Tumors
12.4. Rare Genetic Disorders
12.4.1. Cystic Fibrosis
12.4.2. Sickle Cell Disease
13. Americas Gene Editing Technologies Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Gene Editing Technologies Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Gene Editing Technologies Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Danaher Corporation
16.3.3. Merck KGaA
16.3.4. Roche Holding AG
16.3.5. Agilent Technologies, Inc.
16.3.6. Sartorius AG
16.3.7. Bio-Rad Laboratories, Inc.
16.3.8. QIAGEN N.V.
16.3.9. Lonza Group AG
16.3.10. Takara Bio Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GENE EDITING TECHNOLOGIES MARKET MULTI-CURRENCY
FIGURE 2. GENE EDITING TECHNOLOGIES MARKET MULTI-LANGUAGE
FIGURE 3. GENE EDITING TECHNOLOGIES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GENE EDITING TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. GENE EDITING TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GENE EDITING TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ADENINE BASE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CYTOSINE BASE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CAS9, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY PRIME EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEGANUCLEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TALEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ZFN, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CROPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOFUELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPLASTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIBRARY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY GERMLINE GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOMATIC GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LARGE BIOPHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SMALL AND MEDIUM BIOPHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY GOVERNMENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LIPID NANOPARTICLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MICROINJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ADENO ASSOCIATED VIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY LENTIVIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RETROVIRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY SICKLE CELL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES GENE EDITING TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 124. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 125. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 126. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2030 (USD MILLION)
TABLE 127. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 129. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 130. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 131. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 132. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 133. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 134. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 136. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 137. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2030 (USD MILLION)
TABLE 138. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 139. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 140. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2030 (USD MILLION)
TABLE 141. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 142. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 143. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 144. CANADA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 145. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 146. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 147. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2030 (USD MILLION)
TABLE 148. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 150. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 151. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 152. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 153. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 154. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 155. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 157. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 158. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2030 (USD MILLION)
TABLE 159. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 160. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 161. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2030 (USD MILLION)
TABLE 162. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 163. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 164. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 165. MEXICO GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 186. BRAZIL GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 188. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 189. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2030 (USD MILLION)
TABLE 190. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 192. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 193. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 194. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 195. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 196. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 197. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 199. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 200. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2030 (USD MILLION)
TABLE 201. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 202. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 203. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2030 (USD MILLION)
TABLE 204. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 205. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 206. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 207. ARGENTINA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA GENE EDITING TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 242. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2030 (USD MILLION)
TABLE 244. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 246. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 248. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 250. UNITED KINGDOM GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 251. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 252. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 253. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2030 (USD MILLION)
TABLE 254. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 256. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 257. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 258. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 259. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 260. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 261. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 263. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 264. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2030 (USD MILLION)
TABLE 265. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 266. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 267. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2030 (USD MILLION)
TABLE 268. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 269. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 270. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 271. GERMANY GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 272. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 273. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 274. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2030 (USD MILLION)
TABLE 275. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 276. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 277. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 278. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 279. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 280. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 281. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 282. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 284. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 285. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2030 (USD MILLION)
TABLE 286. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 287. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 288. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2030 (USD MILLION)
TABLE 289. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 290. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 291. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 292. FRANCE GENE EDITING TECHNOLOGIES MARKET SIZE, BY RARE GENETIC DISORDERS, 2018-2030 (USD MILLION)
TABLE 293. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2030 (USD MILLION)
TABLE 294. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CRISPR, 2018-2030 (USD MILLION)
TABLE 295. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BASE EDITING, 2018-2030 (USD MILLION)
TABLE 296. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 297. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY AGRICULTURAL, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH TOOLS, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY EX VIVO, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY IN VIVO, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY MEDICAL CENTERS AND HOSPITALS, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES AND ACADEMIC CENTERS, 2018-2030 (USD MILLION)
TABLE 308. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DELIVERY METHOD, 2018-2030 (USD MILLION)
TABLE 309. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY NONVIRAL, 2018-2030 (USD MILLION)
TABLE 310. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY VIRAL, 2018-2030 (USD MILLION)
TABLE 311. RUSSIA GENE EDITING TECHNOLOGIES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 312. RUSSIA GENE EDITING TECHNOLOGIES MARKE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Gene Editing Technologies market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Roche Holding AG
  • Agilent Technologies, Inc.
  • Sartorius AG
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • Lonza Group AG
  • Takara Bio Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.48 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.75 Billion
Compound Annual Growth Rate12.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

CRISPR Gene Editing Market by Type, Application, End User, Delivery Method - Global Forecast to 2030 - Product Image

CRISPR Gene Editing Market by Type, Application, End User, Delivery Method - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030 - Product Image

CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030

  • Report
  • 120 Pages
  • Global
From
Gene Editing Market by CRISPR, Technology, Application, End User - Global Forecast to 2030 - Product Image

Gene Editing Market by CRISPR, Technology, Application, End User - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Gene Editing - Global Strategic Business Report - Product Image

Gene Editing - Global Strategic Business Report

  • Report
  • 383 Pages
  • Global
From
Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (GRNA Synthesis & Vector Construction), Technique (Knock-Out, Knock-in), Technology (CRISPR, ZFN, TALEN), Application (Genome Editing, Drug Discovery) - Global Forecast to 2029 - Product Image

Gene Editing Market by Product (Kits, Reagents, Libraries, Software), Services (GRNA Synthesis & Vector Construction), Technique (Knock-Out, Knock-in), Technology (CRISPR, ZFN, TALEN), Application (Genome Editing, Drug Discovery) - Global Forecast to 2029

  • Report
  • 498 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.